Shunten International (Holdings) Limited (HKG:0932)
Hong Kong · Delayed Price · Currency is HKD 0.0280
0.00 (0.00%)
Jul 30, 2026, 1:00 PM HKT
HKG:0932 Financials Overview
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 200.28 | 200.28 | 205.05 | 235.59 | 216.13 | 155.64 |
Revenue Growth | -1.89% | -2.32% | -12.96% | 9.00% | 38.86% | -30.25% |
Gross Profit Gross Profit Growth | 152.1 | 152.1 | 157.95 | 184.21 | 166.31 | 107.31 |
Operating Income Operating Income Growth | -4.79 | -4.79 | 4.03 | 26.58 | 33.17 | 0.42 |
Net Income Net Income Growth | -26.57 | -26.57 | -36.24 | 0.57 | 41.04 | -43.89 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.01 | 0.00 | 0.01 | -0.02 |
EPS Growth | - | - | - | -98.61% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Health and Beauty Supplements and Products Business Health and Beauty Supplements and Products Business Growth | 195.68 | 195.68 | 199.92 | 230.58 | 215.92 | 155.64 |
Property Investment Business Property Investment Business Growth | 4.61 | 4.61 | 5.13 | 5.01 | 0.21 | - |
Total Total Growth | 200.28 | 200.28 | 205.05 | 235.59 | 216.13 | 155.64 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 7.37 | 7.37 | 5.53 | 12.7 | 13.11 | 35.28 |
Total Debt Total Debt Growth | 93.83 | 93.83 | 128.92 | 148.09 | 166.41 | 121.6 |
Net Cash (Debt) Net Cash Growth | -86.47 | -86.47 | -123.39 | -135.39 | -153.31 | -86.32 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.03 | -0.03 | -0.04 | -0.04 | -0.05 | -0.03 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 13.96 | 13.96 | 24.02 | 38.78 | 4.84 | 10.47 |
Capital Expenditures CapEx Growth | -0.39 | -0.39 | -0.35 | -4.97 | -1.9 | -0.01 |
Free Cash Flow Free Cash Flow Growth | 13.57 | 13.57 | 23.66 | 33.81 | 2.94 | 10.46 |
Free Cash Flow Growth | 13.02% | -42.66% | -30.00% | 1049.05% | -71.87% | -66.33% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 75.94% | 75.94% | 77.03% | 78.19% | 76.95% | 68.95% |
Operating Margin | -2.39% | -2.39% | 1.97% | 11.28% | 15.35% | 0.27% |
Pretax Margin | -12.94% | -12.94% | -16.27% | 1.94% | 20.25% | -24.73% |
Profit Margin | -13.27% | -13.27% | -17.68% | 0.24% | 18.99% | -28.20% |
FCF Margin | 6.78% | 6.78% | 11.54% | 14.35% | 1.36% | 6.72% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | 315.69 | 5.83 | - |
Forward PE | - | 22.94 | 22.94 | 22.94 | 22.94 | 22.94 |
P/FCF Ratio | 6.41 | 7.10 | 3.15 | 5.33 | 81.34 | 49.93 |
PS Ratio | 0.43 | 0.48 | 0.36 | 0.77 | 1.11 | 3.36 |